Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid

BackgroundDue to the global occurrence of multi-drug-resistant malarial parasites (Plasmodium falciparum), the anti-malarial drug most effective against malaria is artemisinin, a natural product (sesquiterpene lactone endoperoxide) extracted from sweet wormwood (Artemisia annua). However, artemisinin is in short supply and unaffordable to most malaria patients. Artemisinin can be semi-synthesized from its precursor artemisinic acid, which can be synthesized from simple sugars using microorganisms genetically engineered with genes from A. annua. In order to develop an industrially competent yeast strain, detailed analyses of microbial physiology and development of gene expression strategies are required.ResultsThree plant genes coding for amorphadiene synthase, amorphadiene oxidase (AMO or CYP71AV1), and cytochrome P450 reductase, which in concert divert carbon flux from farnesyl diphosphate to artemisinic acid, were expressed from a single plasmid. The artemisinic acid production in the engineered yeast reached 250 μg mL-1 in shake-flask cultures and 1 g L-1 in bio-reactors with the use of Leu2d selection marker and appropriate medium formulation. When plasmid stability was measured, the yeast strain synthesizing amorphadiene alone maintained the plasmid in 84% of the cells, whereas the yeast strain synthesizing artemisinic acid showed poor plasmid stability. Inactivation of AMO by a point-mutation restored the high plasmid stability, indicating that the low plasmid stability is not caused by production of the AMO protein but by artemisinic acid synthesis or accumulation. Semi-quantitative reverse-transcriptase (RT)-PCR and quantitative real time-PCR consistently showed that pleiotropic drug resistance (PDR) genes, belonging to the family of ATP-Binding Cassette (ABC) transporter, were massively induced in the yeast strain producing artemisinic acid, relative to the yeast strain producing the hydrocarbon amorphadiene alone. Global transcriptional analysis by yeast microarray further demonstrated that the induction of drug-resistant genes such as ABC transporters and major facilitator superfamily (MSF) genes is the primary cellular stress-response; in addition, oxidative and osmotic stress responses were observed in the engineered yeast.ConclusionThe data presented here suggest that the engineered yeast producing artemisinic acid suffers oxidative and drug-associated stresses. The use of plant-derived transporters and optimizing AMO activity may improve the yield of artemisinic acid production in the engineered yeast.

[1]  A. Diaspro,et al.  SOD2 functions downstream of Sch9 to extend longevity in yeast. , 2003, Genetics.

[2]  Carl Djerassi,et al.  Magnetic circular dichroism studies. 43. Oxidized cytochrome P-450. Magnetic circular dichroism evidence for thiolate ligation in the substrate-bound form. Implications for the catalytic mechanism , 1976 .

[3]  K. Wood,et al.  Metabolic Engineering of the Phenylpropanoid Pathway in Saccharomyces cerevisiae , 2005, Applied and Environmental Microbiology.

[4]  K. Cal.  Aqueous solubility of liquid monoterpenes at 293 K and relationship with calculated log P value. , 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[5]  J. Boeke,et al.  Designer deletion strains derived from Saccharomyces cerevisiae S288C: A useful set of strains and plasmids for PCR‐mediated gene disruption and other applications , 1998, Yeast.

[6]  Shunji Takahashi,et al.  Metabolic engineering of sesquiterpene metabolism in yeast , 2007, Biotechnology and bioengineering.

[7]  Timothy S. Ham,et al.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.

[8]  Jay D Keasling,et al.  Redirection of flux through the FPP branch‐point in Saccharomyces cerevisiae by down‐regulating squalene synthase , 2008, Biotechnology and bioengineering.

[9]  J. Keasling,et al.  Engineering a mevalonate pathway in Escherichia coli for production of terpenoids , 2003, Nature Biotechnology.

[10]  V. Longo,et al.  Regulation of Longevity and Stress Resistance by Sch9 in Yeast , 2001, Science.

[11]  Jay D. Keasling,et al.  Identification of Isopentenol Biosynthetic Genes from Bacillus subtilis by a Screening Method Based on Isoprenoid Precursor Toxicity , 2007, Applied and Environmental Microbiology.

[12]  K. Jung,et al.  Dissolved-oxygen-stat controlling two variables for methanol induction of rGuamerin in Pichia pastoris and its application to repeated fed-batch , 2003, Applied Microbiology and Biotechnology.

[13]  Jay D Keasling,et al.  Production of isoprenoid pharmaceuticals by engineered microbes , 2006, Nature chemical biology.

[14]  S. Krishna,et al.  Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.

[15]  R. Croteau,et al.  Terpenoid metabolism. , 1995, The Plant cell.

[16]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Marsh.  Malaria disaster in Africa , 1998, The Lancet.

[18]  J. Keasling.  Synthetic biology for synthetic chemistry. , 2008, ACS chemical biology.

[19]  A. R. Fernandes,et al.  The SPI1 Gene, Encoding a Glycosylphosphatidylinositol-Anchored Cell Wall Protein, Plays a Prominent Role in the Development of Yeast Resistance to Lipophilic Weak-Acid Food Preservatives , 2006, Applied and Environmental Microbiology.

[20]  J. Dawson,et al.  Probing structure-function relations in heme-containing oxygenases and peroxidases. , 1988, Science.

[21]  Frances H Arnold,et al.  Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties. , 2007, Angewandte Chemie.

[22]  Daniel J. Vis,et al.  T-profiler: scoring the activity of predefined groups of genes using gene expression data , 2005, Nucleic Acids Res..

[23]  Seung-Keun Hong,et al.  Msn2p/Msn4p Act as a Key Transcriptional Activator of Yeast Cytoplasmic Thiol Peroxidase II* , 2002, The Journal of Biological Chemistry.

[24]  Martin Enserink,et al.  Source of New Hope Against Malaria is in Short Supply , 2005, Science.

[25]  T. Poulos,et al.  High-resolution crystal structure of cytochrome P450cam. , 1987, Journal of molecular biology.

[26]  F. Robert,et al.  Oxidative Stress-Activated Zinc Cluster Protein Stb5 Has Dual Activator/Repressor Functions Required for Pentose Phosphate Pathway Regulation and NADPH Production , 2006, Molecular and Cellular Biology.

[27]  C. Jacq,et al.  Multiple-drug-resistance phenomenon in the yeast Saccharomyces cerevisiae: involvement of two hexose transporters , 1997, Molecular and cellular biology.

[28]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[29]  John Quackenbush,et al.  Genesis: cluster analysis of microarray data , 2002, Bioinform..

[30]  Ted C. J. Turlings,et al.  Recruitment of entomopathogenic nematodes by insect-damaged maize roots , 2005, Nature.

[31]  J. Bohlmann,et al.  Plant terpenoid synthases: molecular biology and phylogenetic analysis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Lewis.  Oxidative stress: the role of cytochromes P450 in oxygen activation , 2002 .

[33]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[34]  Pooja Jain,et al.  The YEASTRACT database: a tool for the analysis of transcription regulatory associations in Saccharomyces cerevisiae , 2005, Nucleic Acids Res..

[35]  J. Gershenzon,et al.  The function of terpene natural products in the natural world. , 2007, Nature chemical biology.

[36]  John R Carney,et al.  Metabolic pathway engineering for complex polyketide biosynthesis in Saccharomyces cerevisiae. , 2006, FEMS yeast research.

[37]  C. Hollenberg,et al.  The presence of a defective LEU2 gene on 2 mu DNA recombinant plasmids of Saccharomyces cerevisiae is responsible for curing and high copy number , 1983, Journal of bacteriology.

[38]  Jay D Keasling,et al.  High‐level production of amorpha‐4,11‐diene in a two‐phase partitioning bioreactor of metabolically engineered Escherichia coli , 2006, Biotechnology and bioengineering.

[39]  A. Osbourn,et al.  Compromised disease resistance in saponin-deficient plants. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Miguel C. Teixeira,et al.  Early transcriptional response of Saccharomyces cerevisiae to stress imposed by the herbicide 2,4-dichlorophenoxyacetic acid. , 2006, FEMS yeast research.

[41]  S. Tenreiro,et al.  Adaptive response to the antimalarial drug artesunate in yeast involves Pdr1p/Pdr3p-mediated transcriptional activation of the resistance determinants TPO1 and PDR5. , 2006, FEMS yeast research.

[42]  R. Snow,et al.  Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. , 2003, The Lancet. Infectious diseases.

[43]  A. R. Fernandes,et al.  Saccharomyces cerevisiae adaptation to weak acids involves the transcription factor Haa1p and Haa1p-regulated genes. , 2005, Biochemical and biophysical research communications.

[44]  C. Djerassi,et al.  Letter: Oxidized cytochrome P-450. Magnetic circular dichroism evidence for thiolate ligation in the substrate-bound form. Implications for the catalytic mechanism. , 1976, Journal of the American Chemical Society.

[45]  J. Gros,et al.  Water solubility, vapor pressure, and activity coefficients of terpenes and terpenoids , 1999 .

[46]  P. Barr,et al.  Production of a polyketide natural product in nonpolyketide-producing prokaryotic and eukaryotic hosts. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Jay D Keasling,et al.  Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. , 2007, Nature chemical biology.